Bright Minds Biosciences Cash Flow Statement (2020-2026) | DRUG

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
2.87M3.85M3.54M2.09M1.72M1.52M1.09M-1.24M2.93M-0.17M0.04M1.99M-7.97M-5.42M-7.63M
Share-based Compensation (Quarter)
0.21M0.30M0.21M0.23M0.23M0.02M0.36M0.02M0.18M0.30M0.16M0.17M0.13M0.15M0.13M0.43M0.95M0.78M0.92M0.88M
Asset Writedowns and Impairment (Quarter)
0.00M0.00M0.00M0.00M0.00M-176.940.00M0.01M0.01M0.00M0.00M
Cash from Restructuring (Quarter)
0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.09M-0.02M-0.02M
Cash from Operations (Quarter)
2.42M-9.73M3.93M2.88M2.24M-19.20M1.96M1.12M1.23M-9.59M0.60M0.60M-0.18M-2.37M1.07M1.69M-8.19M-0.92M-4.17M-6.74M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.01M0.01M0.01M0.01M0.01M-0.02M0.02M0.02M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
-0.09M-0.03M-0.02M0.09M-0.07M0.04M0.02M-0.05M0.02M0.01M0.01M-0.00M-0.01M0.03M-0.03M-0.04M-0.10M-0.04M0.08M
Change in Accured Expenses (Quarter)
-0.06M0.12M0.17M-0.09M-0.70M0.35M0.92M0.44M0.01M-0.47M-0.04M0.12M-0.02M-0.47M1.66M
Investing Activities
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)
-0.02M0.09M0.19M0.66M0.67M0.17M0.01M0.01M0.03M
Change in Capital Stock
Shares Issued (Quarter)
25.97M62.65M89.56M266.73M
Misc.
Cash from Financing Activities (Quarter)
-0.44M-0.01M0.09M0.00M0.01M3.88M1.66M-0.02M-0.02M-0.02M0.64M-0.02M-0.02M-0.02M37.25M0.16M-0.01M24.21M9.60M166.60M
Exchange Rate Effect (Quarter)
0.06M0.12M0.15M-0.01M0.02M0.04M0.01M0.00M0.08M-0.12M-0.03M-0.00M0.03M0.01M1.17M-0.01M-0.56M-0.38M-1.03M1.04M
Change in Cash (Quarter)
-2.86M-1.91M3.83M2.88M2.24M-15.12M-0.30M1.74M1.24M-6.30M0.04M-0.61M0.16M-0.36M36.18M-1.53M-2.54M23.29M5.43M159.86M
Beginning Cash Balance (Quarter)
15.68M8.57M4.96M4.09M59.45M
Free Cash Flow (Quarter)
2.42M-9.73M3.93M2.88M2.24M-19.20M1.96M1.12M1.23M-9.59M0.60M0.60M-0.18M-2.37M1.07M1.69M-8.19M-0.92M-4.17M-6.74M
Net Cash Flow (Quarter)
1.97M-9.74M4.02M2.88M2.25M-15.32M3.62M1.10M1.21M-9.60M1.25M0.58M-0.19M-2.39M38.32M1.85M-8.20M23.29M5.43M159.86M